Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRK5 | P34947 | 16/20 | 1.00 |
| ▸ | GRK2 | P25098 | 8/20 | 1.00 |
| ▸ | MET | P08581 | 7/20 | 0.76 |
| ▸ | FLT3 | P36888 | 1/20 | 0.76 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.72 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13577835 | 0.87 | GRK5 (0.83) | GRK5GRK2METFLT3KCNH2 | |
| SCHEMBL23083306 | 0.86 | GRK5 (1.00) | GRK5GRK2METFLT3 | |
| SCHEMBL13577796 | 0.86 | GRK5 (0.85) | GRK5GRK2METFLT3KCNH2 | |
| SCHEMBL13577797 | 0.85 | MET (0.87) | GRK5GRK2METFLT3KCNH2 | |
| SCHEMBL23083295 | 0.85 | GRK5 (1.00) | GRK5GRK2METFLT3KCNH2 | |
| SCHEMBL2387310 | 0.84 | MET (0.80) | GRK5GRK2METFLT3ALK | |
| SCHEMBL13577846 | 0.84 | MET (0.83) | GRK5GRK2METFLT3KCNH2 | |
| SCHEMBL29351419 | 0.84 | MET (1.00) | GRK5GRK2METFLT3KCNH2 | |
| SCHEMBL2384060 | 0.84 | MET (1.00) | GRK5GRK2METFLT3KCNH2 | |
| Hydrochloric Acid SCHEMBL2748533 | 0.83 | MET (1.00) | GRK5GRK2METFLT3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230035892-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | FLAGSHIP PIONEERING, INC. | 2023-02-02 | — | — | US | disclosed |
| WO-2021046225-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2021-03-11 | — | — | WO | disclosed |